In this video, Dr Laurence Albiges, MD, PhD, Head of the Genitourinary Unit at Gustave Roussy, Villejuif, France, discusses the clinical and biological rationale for combining TKIs and IO in RCC. Dr. Albiges describes the pathophysiology of RCC and shares her thoughts on the preclinical evidence that supports this therapy combination and how this has translated into results in Phase III clinical trials.
230387 – April 2023
